Results 201 to 210 of about 44,642 (305)

Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]

, 1984
Hiller, E., Jochum, Marianne
core  

The effect of antileukemic chemotherapy on elderly patients with acute non-lymphocytic leukemia.

, 1989
Mayumi Mori, Yoshiro Murai, Shinichiro Kurosawa, Hirokazu Kurata, Makiko Hirai, Toshiro Kumakawa, Mutsumi Kawakami, Hisashi Tsutsumi   +7 more
openalex   +2 more sources

Targeting the hypoxia‐inducible factor‐1 alpha‐exoVEGF axis in tumor‐associated macrophages overcomes Bacillus Calmette‐Guérin immunotherapy resistance

Interdisciplinary Medicine, EarlyView.
Macrophages stimulated by BCG significantly enhanced endothelial cell proliferation, migration, and tube formation. Mechanistically, this pro‐angiogenic activity was reliant on activating NF‐αB or other signaling pathways, which induced the upregulation of HIF‐1α and VEGFA.
Yuyang Hou, Yuxi Wang, Qiong Wu, Wenjing Du, Shanzhu Guo, Xinyu Chai, Yinan Wang, Huixin Liang, Hongyan Yuan, Jun Li, Dongmei Yan   +10 more
wiley   +1 more source

Flow cytometric analysis of acute non-lymphocytic leukemia cells

, 1986
Sadao Aoki, Minako Kimura, Shoji Shinada, Akira Shibata   +3 more
openalex   +2 more sources

Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in Vitro [PDF]

, 2003
Xue Meng, Joya Chandra, David A. Loegering, Keri Van Becelaere, Timothy Kottke, Steven D. Gore, Judith E. Karp, Judy Sebolt-Leopold, Scott H. Kaufmann   +8 more
openalex   +1 more source

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
Erin Hickey Zacholski, Jack Dierckes, David Hartnett‐Quach, Cady Noda, Amanda Sharps, Olivia White, Kyle Zacholski, Shawn P. Griffin   +7 more
wiley   +1 more source

Treatment Outcome of Adult Acute Lymphocytic Leukemia with VPDL Regimen: analysis of Prognostic Factors [PDF]

, 2003
Sook Ryun Park, Jee Hyun Kim, Do Yeun Kim, Se‐Hoon Lee, Sang Yoon Lee, In Sil Choi, Sung Soo Yoon, Seon Yang Park, Byuoung Gook Kim, Noe Kyoung Kim   +9 more
openalex   +1 more source

Bifenthrin Under Scrutiny: Revisiting Toxicological Evidence Amid Regulatory Gaps

Journal of Applied Toxicology, EarlyView.
ABSTRACT Despite growing health concerns, bifenthrin (BF) remains widely used for controlling agricultural and residential pests. However, different perspectives on its toxicological profile and regulatory framework warrant a revisit and update on BF regulation towards a robust risk‐safety assessment.
Caroline V. L. Moreira, John Ogbu I, Kadja L. C. Monteiro, Thiago M. de Aquino, Edeildo F. da Silva‐Júnior, Alberto S. S. Filho, Hamilton B. Napolitano, Christianah A. Elusiyan, Renê O. do Couto, Elson A. Costa, James O. Fajemiroye   +10 more
wiley   +1 more source

Clinical Application of Using Diffusion‐Based Wasserstein Generative Adversarial Network for Morphologic Analysis of Blood Cells

Journal of Clinical Laboratory Analysis, EarlyView.
This study evaluated the accuracy of blood cell classification using 78,494 images across 13 cell classes, demonstrating a significant improvement with the DWGAN‐GP augmented dataset. The use of synthetic images increased the classification accuracy to 97.74%, outperforming both unbalanced data and commercial systems.
Hyun‐Young Kim, Emmanuel Edward Ngasa, Hee‐Jin Kim, Boram Kim, Gyujin Lim, Chang‐Hun Park, Hyeon Jeong Kwon, Mi‐Ae Jang, Jiyoung Woo   +8 more
wiley   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source